Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia‐inducible factor 1α axis

Inducing angiogenesis is a hallmark of cancers that sustains tumor growth and metastasis. Neovascularization is a surprisingly early event during the multistage progression of cancer. Cinobufagin, an important bufadienolide originating from Chan Su, has been clinically used to treat cancer in China...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaowu, Chen, Chunhui, Dai, Yu, Huang, Chengzhi, Han, Qinrui, Jing, Linlin, Ma, Ye, Xu, Yihua, Liu, Yawei, Zhao, Liang, Wang, Junjiang, Sun, Xuegang, Yao, Xueqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501006/
https://www.ncbi.nlm.nih.gov/pubmed/30839155
http://dx.doi.org/10.1111/cas.13988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501006/
https://www.ncbi.nlm.nih.gov/pubmed/30839155
http://dx.doi.org/10.1111/cas.13988

Ejemplares similares